May 11, 2022 / 05:00PM GMT
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity Research
We're about to get started with our next company presenter. Thank you for joining us at the BofA Annual Healthcare Conference. My name is Jason Gerberry. I'm one of the biotech analysts at BofA. And I'm pleased to be introducing our next company presenter, Ionis Pharmaceuticals and CFO, Beth Hougen. So Beth, thanks so much for joining us.
Elizabeth L. Hougen - Ionis Pharmaceuticals, Inc. - Executive VP of Finance & CFO
Thanks for having us. It's great to be here and to be in person.
Questions and Answers:
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity ResearchYes. Great. Well, we were talking about this before the start here. But maybe if you can just talk a little bit about Ionis and over the last few years, there's been a lot of changes in terms of the focus, what do you keep in-house? Will you partner? What do you guys want to be as you look to integrate with certain assets and bringing
Trustpilot
